Baird Medical Investment's (BDMD) "Sell (D+)" Rating Reiterated at Weiss Ratings

Key Points

• Baird Medical Investment (NASDAQ: BDMD) has received a "Sell (D+)" rating from Weiss Ratings, reiterating poor performance expectations.
• The stock is currently down 8.6% and trades at $1.59, with a fifty-two week range between $1.05 and $12.50.
• Recent activity from hedge funds shows a mixed approach, with some purchasing new positions while institutional investors hold nearly 20% of the company's stock.

Baird Medical Investment (NASDAQ:BDMD - Get Free Report)'s stock had its "sell (d+)" rating reissued by investment analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.

Separately, Wall Street Zen cut Baird Medical Investment from a "hold" rating to a "sell" rating in a research note on Monday, July 14th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Baird Medical Investment presently has a consensus rating of "Sell".

Baird Medical Investment Stock Down 8.6%

Baird Medical Investment stock traded down $0.15 during midday trading on Wednesday, reaching $1.59. The company's stock had a trading volume of 1,000,472 shares, compared to its average volume of 336,379. Baird Medical Investment has a fifty-two week low of $1.05 and a fifty-two week high of $12.50. The business has a 50-day simple moving average of $2.29 and a 200-day simple moving average of $3.94.

Hedge Funds Weigh In On Baird Medical Investment

Several hedge funds have recently made changes to their positions in BDMD. Jane Street Group LLC purchased a new position in shares of Baird Medical Investment during the second quarter worth about $142,000. XTX Topco Ltd purchased a new position in shares of Baird Medical Investment during the first quarter worth about $111,000. Finally, Geode Capital Management LLC grew its holdings in shares of Baird Medical Investment by 59.7% during the second quarter. Geode Capital Management LLC now owns 25,442 shares of the company's stock worth $93,000 after buying an additional 9,511 shares during the last quarter. Hedge funds and other institutional investors own 19.78% of the company's stock.

About Baird Medical Investment

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.